These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7227431)

  • 1. Antitumoral effect in mice of a new triepoxyde derivative: 1, 3, 5-triglycidyl-s-triazinetrione (NSC 296934).
    Atassi G; Spreafico F; Dumont P; Nayer P; Klastersky J
    Eur J Cancer (1965); 1980 Dec; 16(12):1561-7. PubMed ID: 7227431
    [No Abstract]   [Full Text] [Related]  

  • 2. A characterization of the activity of alpha-1,3,5-triglycidyl-s-triazinetrione, a novel antineoplastic compound.
    Spreafico F; Atassi G; Filippeschi S; Malfiore C; Noseda S; Boschetti D
    Cancer Chemother Pharmacol; 1980; 5(2):103-8. PubMed ID: 7471313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic studies of a novel antitumor drug, alpha-1,3,5-triglycidyl-s-triazinetrione. Antitumor and cytotoxic effects.
    WU FY; Le Pecq JB
    Mol Pharmacol; 1983 Jan; 23(1):182-9. PubMed ID: 6346048
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of dose, schedule and route of administration of 5-formyltetra-hydrofolate: preclinical and clinical investigations.
    Rustum YM; Liu L; Zhang Z
    Adv Exp Med Biol; 1988; 244():39-52. PubMed ID: 3266828
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental antitumor activity and preclinical toxicology of mycophenolic acid.
    Sweeney MJ; Gerzon K; Harris PN; Holmes RE; Poore GA; Williams RH
    Cancer Res; 1972 Sep; 32(9):1795-802. PubMed ID: 4509039
    [No Abstract]   [Full Text] [Related]  

  • 6. In vivo antitumor activity of S 16020-2, a new olivacine derivative.
    Guilbaud N; Kraus-Berthier L; Saint-Dizier D; Rouillon MH; Jan M; Burbridge M; Visalli M; Bisagni E; Pierré A; Atassi G
    Cancer Chemother Pharmacol; 1996; 38(6):513-21. PubMed ID: 8823492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase-I study of alpha-1,3,5-triglycidyl-s-triazinetrione (NSC 296934).
    Dombernowsky P; Lund B; Hansen HH
    Cancer Chemother Pharmacol; 1983; 11(1):59-61. PubMed ID: 6883626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schedule dependence of activity of the amsacrine analogue CI-921 towards P388 leukaemia and Lewis lung carcinoma.
    Baguley BC; Grimwade CD; Kernohan AR
    Eur J Cancer Clin Oncol; 1985 Nov; 21(11):1337-41. PubMed ID: 3841068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of DTIC (NSC-45388) in animals.
    Venditti JM
    Cancer Treat Rep; 1976 Feb; 60(2):135-40. PubMed ID: 1260771
    [No Abstract]   [Full Text] [Related]  

  • 10. alpha-/beta-Triglycidyl-urazol (TGU, NSC 332488, I.N.N.: ANAXIRONE): a new chemotherapeutic agent.
    Hilgard P; Peukert M; Pohl J
    Cancer Treat Rev; 1984 Jun; 11(2):115-20. PubMed ID: 6498858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
    Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
    Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumoral activity of a xanthate compound. II. Therapeutic studies in murine leukemia and tumor models in vivo.
    Schick HD; Danhauser-Riedl S; Amtmann E; Busch R; Reichert A; Steinhauser G; Rastetter J; Sauer G; Berdel WE
    Cancer Lett; 1989 Jul; 46(2):149-52. PubMed ID: 2752384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical and biological characterization of 4'-iodo-4'-deoxydoxorubicin.
    Barbieri B; Giuliani FC; Bordoni T; Casazza AM; Geroni C; Bellini O; Suarato A; Gioia B; Penco S; Arcamone F
    Cancer Res; 1987 Aug; 47(15):4001-6. PubMed ID: 3607745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of the antitumour activity of 2-formylpyridine thiosemicarbazone by metal chelation : 2-formylpyridine thiosemicarbazone zinc sulphate (NSC 294721).
    Atassi G; Dumont P; Harteel JC
    Eur J Cancer (1965); 1979 Apr; 15(4):451-9. PubMed ID: 436906
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of dose, schedule, and route of administration on the in vivo toxicity and antitumor activity of two activated sulfhydryl derivatives of cyclophosphamide.
    Ramonas LM; Erickson LC; Ringsdorf H; Zaharko DS
    Cancer Res; 1980 Oct; 40(10):3704-8. PubMed ID: 7438053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity and antitumor activity of hexamethylmelamine and its N-demethylated metabolites in mice with transplantable tumors.
    Lake LM; Grunden EE; Johnson BM
    Cancer Res; 1975 Oct; 35(10):2858-63. PubMed ID: 808270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity and anticancer activity of a new triazine antifolate (NSC 127755).
    Corbett TH; Leopold WR; Dykes DJ; Roberts BJ; Griswold DP; Schabel FM
    Cancer Res; 1982 May; 42(5):1707-15. PubMed ID: 7066891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental studies of the antitumor activity of amygdalin MF (NSC-15780) alone and in combination with beta-glucosidase (NSC-128056).
    Laster WR; Schabel FM
    Cancer Chemother Rep; 1975; 59(5):951-65. PubMed ID: 1060511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The antitumor activity of intraperitoneally- or orally-administered etoposide in animals and its administration-schedule dependency].
    Okamoto K; Nishikawa K; Seki T; Shibasaki C; Uchida T; Takahashi K
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2331-7. PubMed ID: 4073928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of prumycin.
    Okubo S; Nakamura N; Ito K; Marumo H; Tanaka M; Omura S
    J Antibiot (Tokyo); 1979 Apr; 32(4):347-54. PubMed ID: 468722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.